CG
GNMK

Cutler Group’s GenMark Diagnostics, Inc GNMK Stock Holding History

Cutler Group’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,400
Closed -$7K – 6751
2021
Q1 		$7K Buy
+2,400
New +$44.6K ﹤0.01% 4184
2020
Q4 		– Sell
-1,200
Closed -$1K – 5787
2020
Q3 		$1K Buy
+1,200
New +$18.3K ﹤0.01% 4558
2017
Q4 		– Sell
-2,800
Closed -$1K – 6331
2017
Q3 		$1K Buy
+2,800
New +$29.1K ﹤0.01% 5661
2016
Q3 		– Sell
-8,800
Closed -$1K – 7650
2016
Q2 		$1K Buy
+8,800
New +$60.3K ﹤0.01% 6400

Cutler Group's GNMK Position: Q2 2021 in Review

Cutler Group sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 4,504 shares — an estimated $107K sold.

Cutler Group first reported a position in GNMK in Q3 2016 and held it in 9 quarters. The position peaked at $107K in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

  • Cutler Group reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
  • Cutler Group sold 4,504 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $107K.
  • Cutler Group first reported a position in GenMark Diagnostics, Inc in Q3 2016 and held it in 9 quarters.
  • Cutler Group's GenMark Diagnostics, Inc position peaked at $107K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Cutler Group's 13F filing for Q2 2021, filed 19 Jul 2021.